Recombinant Variola virus Virion membrane protein A17 precursor (A17L, A18L)

What is the Variola virus A17 membrane protein and what is its role in viral replication?

The A17 protein is a conserved viral transmembrane protein essential for crescent formation during poxvirus morphogenesis. It is one of the five most abundant proteins associated with virions and plays a crucial role in the biogenesis of the poxvirus membrane . During a productive infection, A17 is expressed late in the viral replication cycle and contributes to the formation of the viral envelope by promoting membrane curvature .

Methodologically, A17's role in replication has been studied through gene knockout experiments and by expressing the protein under controlled conditions that prevent other viral structural proteins from being synthesized. This is typically accomplished using a bacteriophage T7 promoter system in the presence of cytosine arabinoside (AraC) to prevent viral DNA replication .

How does the structure of A17 contribute to its function in membrane formation?

A17 shares significant topological features with cellular reticulon-like proteins, which are known to promote membrane curvature. While there is no significant amino acid sequence identity between A17 and cellular reticulons, they share key structural characteristics:

• A17 inserts two hairpin structures into the membrane with minimal luminal exposure

• The protein forms homo-oligomers

• The hairpin insertion creates a "wedge effect" that displaces lipid head groups on one side of the membrane, inducing curvature

This structural arrangement allows A17 to physically reshape membranes. When purified A17 protein is incorporated into liposomes, it forms 25 nm diameter vesicles at low concentrations and tubules at higher concentrations, demonstrating its intrinsic ability to generate membrane curvature .

What experimental methods can be used to express and purify recombinant A17 protein?

To express and purify recombinant A17 protein for experimental studies, researchers can use the following methodology:

• Expression system: Create a plasmid encoding the A17 ORF regulated by a bacteriophage T7 promoter

• Cell infection: Transfect the plasmid into cells infected with a recombinant VACV that expresses bacteriophage T7 RNA polymerase

• Prevention of viral replication: Add cytosine arabinoside (AraC) to prevent viral DNA replication and subsequent expression of other viral membrane proteins

• Purification: Extract A17 using membrane protein purification techniques suitable for hydrophobic transmembrane proteins

For functional studies, the purified A17 protein can then be incorporated into liposomes to analyze its membrane-remodeling properties under controlled conditions .

How does A17 interact with cellular membranes during viral replication?

A17 primarily interacts with the endoplasmic reticulum (ER) during viral replication. When expressed in uninfected cells or in infected cells under conditions that prevent synthesis of other viral components, A17 promotes the formation of aggregated 3-dimensional tubular ER networks .

Experimental evidence shows that:

• A17 transforms the ER into these tubular networks even in the absence of other viral structural proteins

• Similar networks containing A17 and ER marker proteins are detected when virion formation is perturbed during infection with certain mutant viruses

• A17 exhibits behavior consistent with reticulon-like proteins that naturally shape the tubular ER

These findings suggest that during infection, A17 hijacks the ER to initiate the formation of viral membranes, effectively repurposing host cellular structures for viral replication.

What experimental approaches are most effective for investigating A17 homo-oligomerization?

Investigating A17 homo-oligomerization requires a combination of biochemical, biophysical, and imaging techniques:

• Cross-linking studies: Chemical cross-linking followed by SDS-PAGE and Western blotting can reveal oligomeric states

• Size exclusion chromatography: To separate and identify different oligomeric forms

• Förster resonance energy transfer (FRET): To detect protein-protein interactions in living cells

• Blue native PAGE: For analysis of membrane protein complexes in their native state

• Cryo-electron microscopy: To visualize the arrangement of A17 oligomers in membranes

Research indicates that A17's homo-oligomerization is functionally significant, as it resembles the behavior of cellular reticulons that form arc-like oligomers to stabilize membrane curvature . When designing oligomerization experiments, researchers should consider the membrane environment, as A17's structure and function are highly dependent on its interaction with lipid bilayers.

How can researchers differentiate between the functions of A17 and other viral membrane proteins in virion assembly?

Differentiating between the functions of A17 and other viral membrane proteins requires several methodological approaches:

• Temporal expression analysis: Study the timing of expression of different viral membrane proteins during infection

• Genetic manipulation:

  • Create conditional lethal mutants for each protein

  • Develop inducible expression systems

  • Utilize RNA interference to selectively suppress expression

• Co-localization studies: Use fluorescent tagging and microscopy to track different proteins

• Protein-protein interaction mapping: Employ techniques such as:

  • Co-immunoprecipitation

  • Proximity ligation assays

  • Yeast two-hybrid screening

  • Mass spectrometry-based interactomics

• Sequential addition experiments: Express A17 first, then add other viral proteins to determine sequential requirements

Research has shown that A17 is essential for crescent formation, while other viral membrane proteins like A14 contribute to later stages of virion assembly. For example, studies using cytosine arabinoside to block viral DNA replication while allowing A17 expression demonstrate that A17 alone can alter ER morphology, suggesting its primary role in initiating membrane curvature .

What are the challenges in studying the A17 protein's role in membrane curvature and how can they be addressed?

Studying A17's role in membrane curvature presents several significant challenges:

Researchers have addressed these challenges by demonstrating that purified A17 protein incorporated into liposomes forms vesicles and tubules that resemble viral structures observed in cells infected with vaccinia virus lacking the A14 membrane protein . This in vitro reconstitution approach provides a controlled system to study A17's intrinsic membrane-remodeling properties.

How might knowledge of A17's structure and function inform antiviral drug development?

A17's essential role in viral replication makes it an attractive target for antiviral drug development. Methodological approaches to leverage this knowledge include:

• Structure-based drug design:

  • Determine the high-resolution structure of A17 using X-ray crystallography or cryo-EM

  • Identify druggable pockets in the protein structure

  • Use computational modeling to screen for small molecules that could disrupt A17 function

• Functional inhibition assays:

  • Develop high-throughput screening assays based on A17's membrane tubulation activity

  • Create cell-based assays monitoring A17-induced ER remodeling

  • Design FRET-based assays to detect disruption of A17 oligomerization

• Antiviral testing in animal models:

  • Test promising compounds in multiple lethal animal models using orthopoxviruses, including vaccinia virus

  • Evaluate effects across a wide range of variables including dosing regimens and treatment timing

  • Consider studies in immunocompromised animals to support drug use in immunocompromised patients

A promising approach would be to target the interface between A17 monomers to prevent oligomerization, as this disruption would likely inhibit A17's ability to induce membrane curvature and thus prevent viral envelope formation .

What methodological considerations are important when investigating A17's evolutionary conservation across poxviruses?

When investigating the evolutionary conservation of A17 across poxviruses, researchers should consider:

• Sequence analysis methodology:

  • Perform multiple sequence alignments of A17 homologs across different poxvirus species

  • Identify conserved functional domains versus variable regions

  • Calculate selection pressures (dN/dS ratios) on different protein regions

• Structural conservation assessment:

  • Compare predicted secondary structures across homologs

  • Analyze conservation of transmembrane domains and topology

  • Identify conserved motifs involved in protein-protein interactions

• Functional conservation testing:

  • Conduct complementation studies by expressing A17 homologs from different poxviruses in A17-deficient vaccinia virus

  • Assess membrane tubulation activities of recombinant A17 proteins from different poxvirus species

  • Examine cross-species protein-protein interactions with conserved binding partners

Evolutionary analyses suggest that much of variola virus evolution occurred relatively recently, with the divergence of the P-I and P-II clades occurring between 1734 and 1793 . This recent timeframe for viral diversification provides context for understanding the high degree of conservation observed in structural proteins like A17 across orthopoxviruses, which is critical for developing broad-spectrum antivirals targeting these conserved proteins.